-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Ferric citrate in end-stage kidney disease as a phosphate binder and source of iron: a review of clinical trials
Diana I Jalal, Mohammed Sika, Jamie P Dwyer, Ingrid J Chang, Barbara A Greco, Marvin Sinsakul, Simin Goral & Kausik Umanath
Drug Evaluation: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 12
Acknowledgements: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
Adverse event monitoring in oncology clinical trials
Jeffery S Russell , A Dimitrios Colevas
Review Article: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation
-
What should be the primary end point in irritable bowel syndrome?
Allen W Mangel
Clinical Trail Prospective: Clinical Investigation